Cargando…
PharmOmics: A species- and tissue-specific drug signature database and gene-network-based drug repositioning tool
Drug development has been hampered by a high failure rate in clinical trials due to our incomplete understanding of drug functions across organs and species. Therefore, elucidating species- and tissue-specific drug functions can provide insights into therapeutic efficacy, potential adverse effects,...
Autores principales: | Chen, Yen-Wei, Diamante, Graciel, Ding, Jessica, Nghiem, Thien Xuan, Yang, Jessica, Ha, Sung-Min, Cohn, Peter, Arneson, Douglas, Blencowe, Montgomery, Garcia, Jennifer, Zaghari, Nima, Patel, Paul, Yang, Xia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957031/ https://www.ncbi.nlm.nih.gov/pubmed/35345455 http://dx.doi.org/10.1016/j.isci.2022.104052 |
Ejemplares similares
-
Network modeling of single-cell omics data: challenges, opportunities, and progresses
por: Blencowe, Montgomery, et al.
Publicado: (2019) -
Mergeomics 2.0: a web server for multi-omics data integration to elucidate disease networks and predict therapeutics
por: Ding, Jessica, et al.
Publicado: (2021) -
Systems toxicogenomics of prenatal low-dose BPA exposure on liver metabolic pathways, gut microbiota, and metabolic health in mice
por: Diamante, Graciel, et al.
Publicado: (2020) -
Drug Repositioning for Diabetes Based on 'Omics' Data Mining
por: Zhang, Ming, et al.
Publicado: (2015) -
A standard database for drug repositioning
por: Brown, Adam S., et al.
Publicado: (2017)